In 2023, the sales of Non-Steroids Antiinflammatory and Antirheumatic Medicine in Chile stood at X million US Dollars PPP. Projections for 2024 indicate a value of 235.8 million USD, with a year-on-year increase of 2.8%. This trend continues with an annual growth rate of approximately 2.8% to 2.5% through to 2028, when sales are expected to reach 261.3 million USD. Over the five-year forecast period (2024-2028), this equates to a Compound Annual Growth Rate (CAGR) of around 2.5%. The notable rise indicates a steady upward trajectory in the market.
Key future trends to monitor include:
• Potential advancements in medical research and technology that could introduce new treatments or enhance existing medications
• Changes in healthcare policies and insurance coverage that might affect prescription rates
• Shifts in consumer preferences towards alternative therapies or over-the-counter solutions
• Economic factors influencing the overall healthcare spending in Chile.
